TruScreen Ltd. | Cash Flow

Fiscal year is April-March. All values NZD Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
1,580.20
692.10
1,296.90
3,540.60
4,168.80
3,502.50
Depreciation, Depletion & Amortization
0.30
64.20
400.80
528.10
536.00
565.80
Other Funds
1,082.70
86.70
39.10
83.50
243.80
253.80
Funds from Operations
497.20
541.20
935.20
3,096.00
3,389.00
2,682.90
Changes in Working Capital
242.30
985.60
273.10
520.40
340.20
4.60
Net Operating Cash Flow
254.90
1,526.80
662.10
2,575.60
3,729.20
2,678.30
Capital Expenditures
46.80
862.60
2,078.90
147.50
3.10
Net Investing Cash Flow
46.80
862.60
2,078.90
147.50
3.10
Issuance/Reduction of Debt, Net
2,750.00
342.20
407.80
-
-
Net Financing Cash Flow
3,141.90
83.50
4,511.40
4,090.00
1,273.20
Net Change in Cash
2,840.20
2,305.90
1,770.40
1,366.90
2,459.10
Free Cash Flow
259.70
1,526.80
669.10
2,581.90
3,732.30
Change in Capital Stock
5,891.90
425.70
4,919.20
4,090.00
1,273.20

About TruScreen

View Profile
Address
Level 6, Equitable House
Auckland AU 1010
New Zealand
Employees -
Website http://www.truscreen.com
Updated 07/08/2019
TruScreen Ltd. engages in the development, manufacture, and sale of cancer detection device and systems. It offers Truscreen Cervical Cancer screening system, which is designed to detect the presence in real time of precancerous and cancerous tissue on the cervix by using optical and electrical measurements of cervical tissue. The company was founded on August 9, 2013 and is headquartered in Auckland, New Zealand.